Job Watch
Short Courses on Innovative Methodologies and Approaches in the Behavioral and Social Sciences (R25 - Independent Clinical Trial Not Allowed)
Funding Opportunity RFA-OD-21-005 from the NIH Guide for Grants and Contracts. The NIH Research Education Program (R25) supports research education activities in the mission areas of the NIH. The overarching goal of this OBSSR R25 program is to support educational activities that complement and/or enhance the training of a workforce to meet the nations biomedical, behavioral and clinical research needs. To accomplish the stated over-arching goal, this FOA will support creative educational activities with a primary focus on Courses for Skills Development. OBSSR and participating Institutes and Centers will support educational activities that develop cross-cutting methodologies and analytics that are needed to more rapidly advance behavioral and social sciences research (BSSR) and are not already well addressed by existing educational programs widely available to the research community. Methodological domains of focus include but are not limited to innovative data collection methodologies and analytic techniques, analysis and linking of big data, or needed but underused designs to advance research across the translational spectrum. Priority will be given to courses that address an important and cross-cutting educational need, that fill a gap in the field not already well addressed by other opportunities and that include a plan for increased reach and sustainability of the training both during and beyond the funding period. Over the period of support, it is expected that the course will be refined, improved, and sufficiently developed and implemented to extend beyond in-person attendance, and beyond the end of the project period (e.g. videos, slides, course materials).
Categories: Job Watch, Literature Watch
Notice of Correction to NOT-OD-21-065 "Notice of Intent to Publish a Research Opportunity Announcement for RADx-UP Return to School Diagnostic Testing Approaches (OT2 Clinical Trial Required)" for Clinical Trial Requirements
Notice NOT-OD-21-072 from the NIH Guide for Grants and Contracts
Categories: Job Watch, Literature Watch
A day in the life of a scientific foundation strategic leader
For Anne-Marie Coriat, improving the academic research system is part of her job
Categories: Job Watch
Research Technician - Human Performance - Careers | West Virginia University - Morgantown, WV
Bioinformatics data analysis for next generation sequencing: Integrative analysis of omic data (genomics, epigenomics, metabolomics, proteomics,…
From West Virginia University - Sun, 14 Mar 2021 10:07:29 GMT - View all Morgantown, WV jobs
From West Virginia University - Sun, 14 Mar 2021 10:07:29 GMT - View all Morgantown, WV jobs
Categories: Job Watch
Postdoctoral Fellow - Microbiology, Immunology and Cell Biology, School of Medicine - Careers | West Virginia University - Morgantown, WV
The position also expects that the candidate devote 50% of time to contribute to team science across the university for collaborative research through genomic…
From West Virginia University - Sun, 14 Mar 2021 10:07:02 GMT - View all Morgantown, WV jobs
From West Virginia University - Sun, 14 Mar 2021 10:07:02 GMT - View all Morgantown, WV jobs
Categories: Job Watch
Upcoming Changes to the Biographical Sketch and Other Support Format Page for Due Dates on or after May 25, 2021
Notice NOT-OD-21-073 from the NIH Guide for Grants and Contracts
Categories: Job Watch, Literature Watch
Innovation Grants to Nurture Initial Translational Efforts (IGNITE): Neurotherapeutic Agent Characterization and In vivo Efficacy Studies (R61/R33 Clinical Trial Not Allowed)
Funding Opportunity PAR-21-122 from the NIH Guide for Grants and Contracts. This FOA provides funding to conduct pharmacodynamic, pharmacokinetic, and in vivo efficacy studies to demonstrate that proposed therapeutic agent(s) have sufficient biological activity to warrant further development to treat neurological or neuromuscular disorders that fall under the NINDS mission. Therapeutic agents include small molecules, biologics or biotechnology-derived products. This FOA is part of a suite of Innovation Grants to Nurture Initial Translational Efforts (IGNITE) to advance projects to the point where they can meet the entry criteria for the Blueprint Neurotherapeutics Network or other translational programs.
Categories: Job Watch, Literature Watch
Innovation Grants to Nurture Initial Translational Efforts (IGNITE): Development and Validation of Model Systems to Facilitate Neurotherapeutic Discovery (R61/R33 Clinical Trial Not Allowed)
Funding Opportunity PAR-21-123 from the NIH Guide for Grants and Contracts. This funding opportunity announcement (FOA) encourages the development and validation of animal models and human/animal tissue ex vivo systems that recapitulate the phenotypic and physiologic characteristics of a defined neurological or neuromuscular disorder. The goal of this FOA is to promote a significant improvement in the translational relevance of animal models or ex vivo systems that will be utilized to facilitate future development of neurotherapeutics. Ideally, models proposed for this FOA would have the potential to provide feasible and meaningful assessments of efficacy following therapeutic intervention that would be applicable in both preclinical and clinical settings. This FOA is part of a suite of Innovation Grants to Nurture Initial Translational Efforts (IGNITE) Program focused on enabling the exploratory and early stages of drug discovery.
Categories: Job Watch, Literature Watch
Innovation Grants to Nurture Initial Translational Efforts (IGNITE): Assay Development and Neurotherapeutic Agent Identification (R61/R33 Clinical Trial Not Allowed)
Funding Opportunity PAR-21-124 from the NIH Guide for Grants and Contracts. This funding opportunity announcement (FOA) encourages research grant applications to develop in vitro and/or ex vivo assays and conduct iterative screening efforts to identify and characterize potential therapeutic agents for neurological or neuromuscular disorders. This FOA is part of a suite of Innovation Grants to Nurture Initial Translational Efforts (IGNITE) to advance projects to the point where they can meet the entry criteria for the Blueprint Neurotherapeutics Network (BPN) or other translational programs.
Categories: Job Watch, Literature Watch
Paramount Recruitment: FAIR Data Manager
Pension, bonus, healthcare:
Paramount Recruitment:
FAIR Data Manager - Germany
We are working exclusively with a client who develop breakthrough therapies and innovative health care solutions in
Baden-Württemberg, Germany
Categories: Job Watch
EMBL: Team Administrator
Competitive Salary:
EMBL:
About this position
We are looking for a Team Administrator to join the Research Office at the European Bioinformatics Institute (EMBL-EBI) located
Hinxton, Cambridgeshire, England
Categories: Job Watch
EMBL: Grants Officer
Competitive Salary:
EMBL:
About this position
We are looking for a Grants Officer to join us at the European Molecular Biology Laboratory – European Bioinformatics Institute
Hinxton, Cambridgeshire, England
Categories: Job Watch
Modular R01s in Cancer Control and Population Sciences (R01 Clinical Trial Optional)
Funding Opportunity PAR-21-190 from the NIH Guide for Grants and Contracts. This funding opportunity announcement (FOA) encourages applications for research in cancer control and population sciences. The overarching goal is to provide support to promote research efforts on novel scientific ideas that have the potential to substantially advance cancer research in statistical and analytic methods, epidemiology, cancer survivorship, cancer-related behaviors and behavioral interventions, health care delivery, and implementation science.
Categories: Job Watch, Literature Watch
Notice of Special Interest: Innovative Approaches or Technologies to Investigate Regional, Structural and Functional Heterogeneity of CNS Small Blood and Lymphatic Vessels in AD/ADRD
Notice NOT-NS-21-039 from the NIH Guide for Grants and Contracts
Categories: Job Watch, Literature Watch
Scientist - R&D - Proteovista LLC - Madison, WI
(4) Laboratory expertise with nucleic acid microarrays, next gen sequencing, bioinformatics, and data analysis is a plus; Social distancing guidelines in place. $20 - $30 an hour
From Indeed - Thu, 11 Mar 2021 22:29:46 GMT - View all Madison, WI jobs
From Indeed - Thu, 11 Mar 2021 22:29:46 GMT - View all Madison, WI jobs
Categories: Job Watch
Notice of NIAMS Participation in NOT-EB-21-001 "Notice of Special Interest (NOSI): Small Business Initiatives for Innovative Diagnostic Technology for Improving Outcomes for Maternal Health"
Notice NOT-AR-21-019 from the NIH Guide for Grants and Contracts
Categories: Job Watch, Literature Watch
Notice of Special Interest (NOSI): Understanding and Addressing the Impact of Structural Racism and Discrimination on Biomedical Career Progression and the Biomedical Research Enterprise
Notice NOT-GM-21-033 from the NIH Guide for Grants and Contracts
Categories: Job Watch, Literature Watch
Paramount Recruitment: Bioinformatics Post-Doc Opportunity
GBP35000 - GBP48000 per annum:
Paramount Recruitment:
Bioinformatics Post-Doc- Pipeline Developer
Cambridge
This is a great opportunity for a Bioinformatics/Comp Bio/Data Science/Statistical Genetics
Cambridge, England
Categories: Job Watch
Notice of Early Expiration of NOT-MH-21-075 Notice of Special Interest (NOSI) regarding the Use of Human Connectome Data for Secondary Analysis
Notice NOT-MH-21-210 from the NIH Guide for Grants and Contracts
Categories: Job Watch, Literature Watch
Innovations for Healthy Living - Improving Minority Health and Eliminating Health Disparities (R43/R44 - Clinical Trial Optional)
Funding Opportunity RFA-MD-21-006 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) invites eligible United States small business concerns (SBCs) to submit Small Business Innovation Research (SBIR) grant applications that propose to conduct innovative research supporting the development of a product, tool, technology, process or service for commercialization with the aim of eliminating disparities in socioeconomically disadvantaged populations, underserved rural populations, and sexual and gender minority populations or improving health in racial/ethnic minority populations.
Categories: Job Watch, Literature Watch
Pages
